Drone Biological Samples Transport vs Walking (DBT - Drone Biology Transport) (DBT)

March 4, 2024 updated by: University Hospital, Caen

Drone Biological Samples Transport Evaluation Compared to Walking in CHU CAEN NORMANDIE

The transport of biological samples is a key step in the pre-analysis process in health facilities and must meet quality requirements (NF:EN:ISO 151989) to ensure that samples are transported in are transported in good conditions.

Still in the experimental stage, drone-based air transport is participating in the aeronautical revolution of the development of unmanned aircraft on board in all areas of society, including health.

This first project, led by the Biology Centre and the INNOVABIO Biological Resources Centre of the CHU de CAEN in collaboration with the company Delivrone, will allow to evaluate the feasibility in real condition of the mode of transport by drone versus transport of reference on the quality of a varied panel of medical biology examinations (biochemistry, hematology and haemostasis), on the safety of people (potentially infectious samples), on the control of the delivery time, on the control of the transport temperature (15-25°C ). The samples will be taken on 30 healthy volunteers with a total panel of 23 blood tests performed.

Study Overview

Status

Completed

Conditions

Detailed Description

Panel of blood tests performed on healthy volunteers samples include :

  • Na, K, Cl, HC03-
  • total protein
  • Ca
  • Creatinine, urea
  • Albumine
  • Bilirubin
  • Liver transaminases (ALT, AST)
  • Alkaline phosphatase
  • GGT
  • LDH
  • C-reactive protein
  • Complete Blood Count
  • Sedimentation rate
  • PT
  • aPTT
  • Fibrinogen
  • D-Dimer

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Caen, France, 14000
        • CHU Caen Normandie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers

Description

Inclusion Criteria:

  • Healthy volunteers, over 18 years old

Exclusion Criteria:

  • Unhealthy volunteers previously known
  • pregnant or breastfeeding woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pedestrian transport
Modality of transport currently used
Biological samples transport and analysis
Drone transport
Innovative modality of transport
Biological samples transport and analysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact on Sodium test
Time Frame: 1 day
Evaluation difference between results of Sodium (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on Potassium test
Time Frame: 1 day
Evaluation difference between results of Potassium (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on Chlorure test
Time Frame: 1 day
Evaluation difference between results of Chlorure (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on Bicarbonate test
Time Frame: 1 day
Evaluation difference between results of Bicarbonate (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on Protein test
Time Frame: 1 day
Evaluation difference between results of Protein (g/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on Calcium test
Time Frame: 1 day
Evaluation difference between results of Calcium (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on Creatinin test
Time Frame: 1 day
Evaluation difference between results of Creatinin (µmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on Urea test
Time Frame: 1 day
Evaluation difference between results of Urea (mmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on Albumin test
Time Frame: 1 day
Evaluation difference between results of Albumin (g/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on Bilirubin test
Time Frame: 1 day
Evaluation difference between results of Bilirubin (µmol/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on liver transaminase (ALT) test
Time Frame: 1 day
Evaluation difference between results of liver transaminase (ALT, U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on liver transaminase (AST) test
Time Frame: 1 day
Evaluation difference between results of liver transaminase (AST, U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on alkalin phosphatase test
Time Frame: 1 day
Evaluation difference between results of alkalin phosphatase (U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on GGT test
Time Frame: 1 day
Evaluation difference between results of GGT (U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on LDH test
Time Frame: 1 day
Evaluation difference between results of LDH (U/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on C-reactive Protein test
Time Frame: 1 day
Evaluation difference between results of C-reactive Protein (mg/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on red blood cells count
Time Frame: 1 day
Evaluation difference between results of red blood cells (T/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on hemoglobin test
Time Frame: 1 day
Evaluation difference between results of hemoglobin (g/dL) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on white blood cells count
Time Frame: 1 day
Evaluation difference between results of white blood cells (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on neutrophil cells count
Time Frame: 1 day
Evaluation difference between results of neutrophil cells (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on lymphocytes cells count
Time Frame: 1 day
Evaluation difference between results of lymphocytes cells (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on platelets count
Time Frame: 1 day
Evaluation difference between results of platelets (G/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on sedimentation rate test
Time Frame: 1 day
Evaluation difference between results of sedimentation rate (mm) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on PT test
Time Frame: 1 day
Evaluation difference between results of PT (sec and %) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on a-PTT test
Time Frame: 1 day
Evaluation difference between results of a-PTT (sec) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on Fibrinogen test
Time Frame: 1 day
Evaluation difference between results of Fibrinogen (g/L) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day
Impact on D-Dimer test
Time Frame: 1 day
Evaluation difference between results of D-Dimer (ng/mL) after drone transport (30 samples) versus pedestrian transport (30 samples).
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the users security
Time Frame: 1 day
Report accident of drone or users injuries
1 day
Evaluation of the users safety
Time Frame: 1 day
Report numbers of samples broken (contamination risk) after drone transport
1 day
Temperature
Time Frame: 1 day
Temperature measurement during the transport. Evaluation of the ambient temperature respect during the transport in the two conditions.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Benjamin GILLET, MD, CHU Caen Normandie

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 27, 2023

Primary Completion (Actual)

August 27, 2023

Study Completion (Actual)

August 30, 2023

Study Registration Dates

First Submitted

March 23, 2023

First Submitted That Met QC Criteria

July 20, 2023

First Posted (Actual)

July 24, 2023

Study Record Updates

Last Update Posted (Actual)

March 5, 2024

Last Update Submitted That Met QC Criteria

March 4, 2024

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 22-0238
  • 2022-A02548-35 (Registry Identifier: ID RCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Biological samples transport and analysis

Subscribe